DK1131348T3 - Regulatoriske/udfoldende peptider af ezrin - Google Patents

Regulatoriske/udfoldende peptider af ezrin

Info

Publication number
DK1131348T3
DK1131348T3 DK00962685T DK00962685T DK1131348T3 DK 1131348 T3 DK1131348 T3 DK 1131348T3 DK 00962685 T DK00962685 T DK 00962685T DK 00962685 T DK00962685 T DK 00962685T DK 1131348 T3 DK1131348 T3 DK 1131348T3
Authority
DK
Denmark
Prior art keywords
ezrin
regulatory
unfolding
peptides
unfolding peptides
Prior art date
Application number
DK00962685T
Other languages
English (en)
Inventor
Rupert Donald Holms
Original Assignee
Rupert Donald Holms
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rupert Donald Holms filed Critical Rupert Donald Holms
Application granted granted Critical
Publication of DK1131348T3 publication Critical patent/DK1131348T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK00962685T 1999-09-17 2000-09-15 Regulatoriske/udfoldende peptider af ezrin DK1131348T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9921881A GB2354241A (en) 1999-09-17 1999-09-17 Regulatory/unfolding peptides of ezrin
PCT/GB2000/003566 WO2001025275A1 (en) 1999-09-17 2000-09-15 Regulatory/unfolding peptides of ezrin

Publications (1)

Publication Number Publication Date
DK1131348T3 true DK1131348T3 (da) 2007-07-09

Family

ID=10861009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00962685T DK1131348T3 (da) 1999-09-17 2000-09-15 Regulatoriske/udfoldende peptider af ezrin

Country Status (23)

Country Link
US (1) US6849596B1 (da)
EP (2) EP1760090A1 (da)
JP (1) JP2003511389A (da)
KR (1) KR20010101017A (da)
CN (1) CN100387619C (da)
AT (1) ATE356144T1 (da)
AU (1) AU770208B2 (da)
BR (1) BR0007158A (da)
CA (1) CA2348780A1 (da)
CY (1) CY1106644T1 (da)
CZ (1) CZ20011689A3 (da)
DE (1) DE60033783T2 (da)
DK (1) DK1131348T3 (da)
ES (1) ES2283317T3 (da)
GB (1) GB2354241A (da)
HU (1) HUP0104254A3 (da)
NO (1) NO20012417L (da)
NZ (1) NZ511747A (da)
PL (1) PL348635A1 (da)
PT (1) PT1131348E (da)
RU (1) RU2215005C2 (da)
WO (1) WO2001025275A1 (da)
ZA (1) ZA200103938B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0301879D0 (en) * 2003-01-27 2003-02-26 Regent Res Llp HCV combination therapy
WO2007060440A2 (en) * 2005-11-23 2007-05-31 Regent Research L.L.P. The use of peptides in anti-ulcer therapy
CN100455665C (zh) * 2006-11-21 2009-01-28 汕头大学医学院 人食管癌细胞ezrin基因上游转录调控元件
WO2009103312A1 (en) * 2008-02-19 2009-08-27 Ludwig-Maximilians-Universität Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
RU2580629C1 (ru) * 2015-05-15 2016-04-10 Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ прогнозирования рецептивности эндометрия на основании оценки экспрессии и внутриклеточной локализации эзрина в эндометрии женщин с бесплодием и повторными неудачами программы эко
WO2016193285A1 (en) * 2015-06-01 2016-12-08 Nearmedic International Limited Ezrin-derived peptides and pharmaceutical compositions thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290293A (en) * 1994-06-08 1995-12-20 Rupert Donald Holms Preparation which inhibits the autoimmune response in HIV, or SLE, patients
US6251586B1 (en) * 1995-10-02 2001-06-26 The United States Of America As Represented By The Department Of Health And Human Services Epithelial protein and DNA thereof for use in early cancer detection
US6399584B1 (en) * 1998-03-18 2002-06-04 Institute Curie Pharmaceutical composition containing ezrin mutated on tyrosine 353

Also Published As

Publication number Publication date
CY1106644T1 (el) 2012-01-25
RU2215005C2 (ru) 2003-10-27
DE60033783D1 (de) 2007-04-19
GB2354241A (en) 2001-03-21
EP1131348B1 (en) 2007-03-07
CA2348780A1 (en) 2001-04-12
KR20010101017A (ko) 2001-11-14
AU7433300A (en) 2001-05-10
PT1131348E (pt) 2007-11-19
EP1760090A1 (en) 2007-03-07
NZ511747A (en) 2004-03-26
HUP0104254A2 (hu) 2002-04-29
GB9921881D0 (en) 1999-11-17
EP1131348A1 (en) 2001-09-12
CN1327450A (zh) 2001-12-19
HUP0104254A3 (en) 2002-05-28
NO20012417L (no) 2001-07-16
JP2003511389A (ja) 2003-03-25
BR0007158A (pt) 2001-07-31
WO2001025275A9 (en) 2002-07-25
WO2001025275A1 (en) 2001-04-12
AU770208B2 (en) 2004-02-19
ATE356144T1 (de) 2007-03-15
CN100387619C (zh) 2008-05-14
ZA200103938B (en) 2002-05-15
DE60033783T2 (de) 2007-11-15
PL348635A1 (en) 2002-06-03
NO20012417D0 (no) 2001-05-16
US6849596B1 (en) 2005-02-01
ES2283317T3 (es) 2007-11-01
CZ20011689A3 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
DE69910580D1 (de) Von der telomerase abgeleitete antigene peptide
DK1191852T3 (da) Indretning til forarbejdning af et slagteprodukt
DE69903671D1 (de) Integriertes auflichtprojektionssystem
MA24422A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotrachaite infectieuse aviaire.
DK1210113T3 (da) Kombinerede vaccinepræparater
ES2110386T3 (es) Conjugados de interferon.
EE200100516A (et) Makrotsüklilised peptiidid, mis on aktiivsed C-hepatiidi viiruse vastu
ID22977A (id) Konjugasi polietilen glikol-interferon alfa untuk terapi suatu infeksi
ATE275631T1 (de) Rekombinanter venezolanische-equine- pferdeenzephalitis-virusimpstoff
NO20001240D0 (no) Kay-A immunsystemprotein
FR12C0004I1 (da)
NO992102L (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
NO905326L (no) Kirurgisk klemme.
DE60234840D1 (de) Ascomycin enthaltende ophthalmische zubereitungen
NO974562L (no) Antifugale, cykliske peptider
DE69101683D1 (de) Rekombinantes Mareks-Krankheitsvirus.
NO20041300L (no) Flavanolignanpreparater med okt loselighet
DK1131348T3 (da) Regulatoriske/udfoldende peptider af ezrin
BR9712067A (pt) Pept¡dios imunog-nicos de v¡rus da doen-a de febre aftosa
NO20033829L (no) Virusdrepende preparater
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
TR200200926T2 (tr) Isıyla şekillendirilebilen poliamidler.
IS2797B (is) Bóluefni gegn ISA-veiru
NO20013933D0 (no) Peptider
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.